ID   P388
AC   CVCL_7222
SY   P-388
DR   BTO; BTO:0000748
DR   CLO; CLO_0008321
DR   CLO; CLO_0050216
DR   CLDB; cl3829
DR   BCRJ; 0198
DR   CCRID; 1102MOU-NIFDC00073
DR   ChEMBL-Cells; CHEMBL3308401
DR   ChEMBL-Targets; CHEMBL389
DR   JCRB; JCRB0017
DR   NCI-DTP; P388
DR   PubChem_Cell_line; CVCL_7222
DR   RCB; RCB2776
DR   TKG; TKG 0326
DR   Wikidata; Q54937248
RX   CelloPub=CLPUB00459;
RX   PubMed=3335022;
RX   PubMed=10516761;
RX   PubMed=13541471;
WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 22
//
RX   CelloPub=CLPUB00459;
RA   Dawe C.J., Potter M.;
RT   "Morphologic and biologic progression of a lymphoid neoplasm of the
RT   mouse in vivo and in vitro.";
RL   Am. J. Pathol. 33:603-603(1957).
//
RX   PubMed=3335022;
RA   Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J.,
RA   Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.;
RT   "Feasibility of drug screening with panels of human tumor cell lines
RT   using a microculture tetrazolium assay.";
RL   Cancer Res. 48:589-601(1988).
//
RX   PubMed=10516761; DOI=10.1038/sj.leu.2401518;
RA   Coleman A.E., Forest S.T., McNeil N.E., Kovalchuk A.L., Ried T.,
RA   Janz S.;
RT   "Cytogenetic analysis of the bipotential murine pre-B cell lymphoma,
RT   P388, and its derivative macrophage-like tumor, P388D1, using SKY and
RT   CGH.";
RL   Leukemia 13:1592-1600(1999).
//
RX   PubMed=13541471; DOI=10.1038/1811343a0;
RA   Rabson A.S., Legallais F.Y., Baron S.;
RT   "Adaptation to serum-free medium by a phagocytic cell strain derived
RT   from a murine lymphoma.";
RL   Nature 181:1343-1343(1958).
//